Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AMARC Enterprises is a health and wellness company primarily known for the manufacture and distribution of Poly-MVA, a unique dietary supplement. Poly-MVA is a patented formulation consisting of a liquid complex of alpha-lipoic acid and the mineral palladium, designed to support cellular energy production and mitochondrial function. The company positions its products within the integrative and complementary medicine space, often used by individuals seeking nutritional support during conventional cancer treatments or for general cellular health. AMARC Enterprises focuses on providing non-toxic, nutrient-based solutions to enhance quality of life and metabolic efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AMARC Enterprises.